3 E NETWORK TECHNOLOGY GRP-A (MASK) Fundamental Analysis & Valuation

NASDAQ:MASK • VGG8849D1107

Current stock price

1.37 USD
-0.51 (-27.13%)
At close:
1.36 USD
-0.01 (-0.73%)
After Hours:

This MASK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MASK Profitability Analysis

1.1 Basic Checks

  • In the past year MASK was profitable.
  • MASK had a positive operating cash flow in the past year.
MASK Yearly Net Income VS EBIT VS OCF VS FCFMASK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 500K 1M 1.5M

1.2 Ratios

  • The Return On Assets of MASK (19.61%) is better than 97.73% of its industry peers.
  • MASK has a better Return On Equity (34.26%) than 93.18% of its industry peers.
  • The Return On Invested Capital of MASK (40.30%) is better than 98.86% of its industry peers.
Industry RankSector Rank
ROA 19.61%
ROE 34.26%
ROIC 40.3%
ROA(3y)32.62%
ROA(5y)N/A
ROE(3y)51.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MASK Yearly ROA, ROE, ROICMASK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 50 100

1.3 Margins

  • Looking at the Profit Margin, with a value of 23.03%, MASK belongs to the top of the industry, outperforming 96.59% of the companies in the same industry.
  • MASK's Profit Margin has declined in the last couple of years.
  • MASK has a better Operating Margin (39.87%) than 98.86% of its industry peers.
  • In the last couple of years the Operating Margin of MASK has grown nicely.
  • MASK has a better Gross Margin (50.26%) than 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of MASK has declined.
Industry RankSector Rank
OM 39.87%
PM (TTM) 23.03%
GM 50.26%
OM growth 3Y1.96%
OM growth 5YN/A
PM growth 3Y-22.43%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
MASK Yearly Profit, Operating, Gross MarginsMASK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 500 1K 1.5K 2K 2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. MASK Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MASK is creating value.
  • The number of shares outstanding for MASK has been increased compared to 1 year ago.
  • MASK has a worse debt/assets ratio than last year.
MASK Yearly Shares OutstandingMASK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 2M 4M 6M 8M 10M
MASK Yearly Total Debt VS Total AssetsMASK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • MASK has an Altman-Z score of 11.14. This indicates that MASK is financially healthy and has little risk of bankruptcy at the moment.
  • MASK's Altman-Z score of 11.14 is amongst the best of the industry. MASK outperforms 94.32% of its industry peers.
  • The Debt to FCF ratio of MASK is 78.28, which is on the high side as it means it would take MASK, 78.28 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 78.28, MASK is in line with its industry, outperforming 40.91% of the companies in the same industry.
  • MASK has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of MASK (0.20) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 78.28
Altman-Z 11.14
ROIC/WACC4.22
WACC9.54%
MASK Yearly LT Debt VS Equity VS FCFMASK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 1M 2M 3M 4M 5M

2.3 Liquidity

  • MASK has a Current Ratio of 2.46. This indicates that MASK is financially healthy and has no problem in meeting its short term obligations.
  • MASK has a better Current ratio (2.46) than 70.45% of its industry peers.
  • MASK has a Quick Ratio of 2.46. This indicates that MASK is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 2.46, MASK is doing good in the industry, outperforming 70.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 2.46
MASK Yearly Current Assets VS Current LiabilitesMASK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MASK Growth Analysis

3.1 Past

  • The earnings per share for MASK have decreased strongly by -13.61% in the last year.
  • The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth
  • Looking at the last year, MASK shows a very strong growth in Revenue. The Revenue has grown by 107.85%.
  • Measured over the past years, MASK shows a very strong growth in Revenue. The Revenue has been growing by 55.08% on average per year.
EPS 1Y (TTM)-13.61%
EPS 3Y21.42%
EPS 5YN/A
EPS Q2Q%-46.15%
Revenue 1Y (TTM)107.85%
Revenue growth 3Y55.08%
Revenue growth 5YN/A
Sales Q2Q%462.69%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MASK Yearly Revenue VS EstimatesMASK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 1M 2M 3M 4M

More info and screens

Find the best growth stocksShow best growing peers

3

4. MASK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.06, which indicates a very decent valuation of MASK.
  • 79.55% of the companies in the same industry are more expensive than MASK, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of MASK to the average of the S&P500 Index (24.88), we can say MASK is valued rather cheaply.
Industry RankSector Rank
PE 8.06
Fwd PE N/A
MASK Price Earnings VS Forward Price EarningsMASK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Price/Free Cash Flow ratio as MASK.
Industry RankSector Rank
P/FCF 2861.12
EV/EBITDA N/A
MASK Per share dataMASK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15 0.2 0.25

4.3 Compensation for Growth

  • The decent profitability rating of MASK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MASK Dividend Analysis

5.1 Amount

  • MASK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MASK Fundamentals: All Metrics, Ratios and Statistics

3 E NETWORK TECHNOLOGY GRP-A

NASDAQ:MASK (3/27/2026, 8:00:00 PM)

After market: 1.36 -0.01 (-0.73%)

1.37

-0.51 (-27.13%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners7.82%
Inst Owner ChangeN/A
Ins Owners45.7%
Ins Owner Change0%
Market Cap39.48M
Revenue(TTM)7.96M
Net Income(TTM)1.83M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.06
Fwd PE N/A
P/S 4.96
P/FCF 2861.12
P/OCF 2861.12
P/B 7.37
P/tB 7.37
EV/EBITDA N/A
EPS(TTM)0.17
EY12.41%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.03%
OCF(TTM)0
OCFY0.03%
SpS0.28
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.84
Profitability
Industry RankSector Rank
ROA 19.61%
ROE 34.26%
ROCE 49.35%
ROIC 40.3%
ROICexc 42.37%
ROICexgc 42.37%
OM 39.87%
PM (TTM) 23.03%
GM 50.26%
FCFM 0.17%
ROA(3y)32.62%
ROA(5y)N/A
ROE(3y)51.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-24.87%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.87%
ROICexc growth 5YN/A
OM growth 3Y1.96%
OM growth 5YN/A
PM growth 3Y-22.43%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
F-Score4
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 78.28
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 0.75%
Current Ratio 2.46
Quick Ratio 2.46
Altman-Z 11.14
F-Score4
WACC9.54%
ROIC/WACC4.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)10.33%
Cap/Sales(5y)N/A
Profit Quality(3y)50.38%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.61%
EPS 3Y21.42%
EPS 5YN/A
EPS Q2Q%-46.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)107.85%
Revenue growth 3Y55.08%
Revenue growth 5YN/A
Sales Q2Q%462.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y95.9%
EBIT growth 3Y58.12%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.51%
FCF growth 3Y-75.5%
FCF growth 5YN/A
OCF growth 1Y-98.51%
OCF growth 3Y-75.8%
OCF growth 5YN/A

3 E NETWORK TECHNOLOGY GRP-A / MASK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for 3 E NETWORK TECHNOLOGY GRP-A?

ChartMill assigns a fundamental rating of 5 / 10 to MASK.


What is the valuation status for MASK stock?

ChartMill assigns a valuation rating of 3 / 10 to 3 E NETWORK TECHNOLOGY GRP-A (MASK). This can be considered as Overvalued.


Can you provide the profitability details for 3 E NETWORK TECHNOLOGY GRP-A?

3 E NETWORK TECHNOLOGY GRP-A (MASK) has a profitability rating of 6 / 10.


What is the valuation of 3 E NETWORK TECHNOLOGY GRP-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for 3 E NETWORK TECHNOLOGY GRP-A (MASK) is 8.06 and the Price/Book (PB) ratio is 7.37.